Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in BMJ Retrieve available abstracts of 12 articles: HTML format

Single Articles

March 2023
1. MAHASE E
   First hepatitis D medicine is given restricted approval in Scotland after US rejection.
   BMJ. 2023;380:p660.
   PubMed    
   
   
   February 2023
2. 
   Diagnosis and management of autoimmune hepatitis.
   BMJ. 2023;380:p330.
   PubMed    
   
   
   
3. MURATORI L, Lohse AW, Lenzi M
   Diagnosis and management of autoimmune hepatitis.
   BMJ. 2023;380:e070201.
   PubMed     Abstract available
   
   
   July 2022
4. WISE J
   Paediatric hepatitis is linked to infection with two viruses, studies find.
   BMJ. 2022;378:o1876.
   PubMed    
   
   
   June 2022
5. SALMON R, Palmer S
   Recent hepatitis outbreak in children may have a foodborne toxin as its cause.
   BMJ. 2022;377:o1518.
   PubMed    
   
   
   May 2022
6. CEVIK M, Rasmussen AL, Bogoch II, Kindrachuk J, et al
   Acute hepatitis of unknown origin in children.
   BMJ. 2022;377:o1197.
   PubMed    
   
   
   
7. IACOBUCCI G
   Acute hepatitis is identified in more children, but cause remains elusive.
   BMJ. 2022;377:o1156.
   PubMed    
   
   
   
8. MAHASE E
   Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO.
   BMJ. 2022;377:o1132.
   PubMed    
   
   
   April 2022
9. MAHASE E
   Hepatitis in children: What's behind the outbreaks?
   BMJ. 2022;377:o1067.
   PubMed    
   
   
   
10. CHRISTIE B
    Scientists search for cause of hepatitis cases in children.
    BMJ. 2022;377:o982.
    PubMed    
    
    
    May 2021
11. MEHTA SJ, Day SC, Norris AH, Sung J, et al
    Behavioral interventions to improve population health outreach for hepatitis C screening: randomized clinical trial.
    BMJ. 2021;373:n1022.
    PubMed     Abstract available
    
    
    
12. 
    Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
    BMJ. 2021;373:n1130.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: